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Abstract The diagnosis of cognitive impairment and
dementia often occurring with Parkinson’s disease (PD) is
still based on the clinical picture and neuropsychological
examination. Ancillary methods to detect cognitive decline
in these patients are, therefore, needed. Alterations in the
latencies and amplitudes of evoked response potential
(ERP) components N100 and P200 have been described in
PD. Due to limited number of studies their relation to
cognitive deficits in PD remains obscure. The present study
was designed to examine if alterations in the N100- and
P200-potentials associate with neuropsychological impair-
ment in PD. EEG-ERP was conducted to 18 PD patients
and 24 healthy controls. The patients underwent a thorough
neuropsychological evaluation. The controls were screened
for cognitive impairment with Consortium to Establish
Alzheimer’s disease (CERAD)—testing and a normal
result were required to be included in the study. The N100-
latency was prolonged in the patients compared to the
controls (p = 0.05). In the patients, the N100 latency
correlated significantly with a visual working memory task
(p = 0.01). Also N100 latency was prolonged and N100
amplitude habituation diminished in the patients achieving
poorly in this task. We conclude that prolonged N100-
latency and diminished amplitude habituation associate
with visual working memory impairment in PD.
Keywords Evoked response potential  Cognition 
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Introduction
Parkinson’s disease (PD) is a complex neurodegenerative
disorder with motor, autonomous and cognitive symptoms.
The motor symptoms dominate the clinical picture espe-
cially in the early stages of the disease. However, neu-
ropsychological testing often reveals subtle cognitive
changes typical of PD even at the early stages of the dis-
ease. Verbal and visual memory deficits, executive dys-
function, problems in language and attention are the most
prevalent findings (Aarsland et al. 2008; Muslimovic et al.
2005; Pfeiffer et al. 2014; Uc et al. 2005) that in some
patients deepen to the level of mild cognitive impairment
(PD-MCI). As the disease progresses, the neuropsycho-
logical symptoms tend to advance and a substantial pro-
portion of the patients with PD-MCI will develop
Parkinson’s disease dementia (PDD) during its course
(Aarsland et al. 2003; Pigott et al. 2015; Riedel et al. 2008).
Movement Disorder Society has recently published
guidelines to diagnose both PD-MCI (Litvan et al. 2012)
and PDD (Emre et al. 2007). According to the guidelines
the diagnosis of PD-MCI and PDD are based on clinical
and neuropsychological evaluation and ruling out other
causes. As to date, there are no clinically applicable
ancillary methods to establish PD-MCI or PDD. The situ-
ation is, therefore, different from the other common
dementias, such as Alzheimer’s disease and vascular
dementia, where brain imaging findings are an essential
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part of the diagnosis. New methods to examine cognition in
PD are needed not only to diagnose dementia but also to
identify at-risk patients to support the preservation of
cognition and hopefully in the future offer medication to
prevent future cognitive decline.
Electroencephalogram (EEG) with evoked response
potentials (ERP) is a safe and non-invasive method in
providing real-time information of the brain’s response to
sensory stimuli indicating not only stimulus detection but
also ensuing conscious processing and orienting to novel
stimuli. The ERPs have been examined in Parkinson’s
disease (Green et al. 1996; Hayashi et al. 1996; Hozumi
et al. 2000; Katsarou et al. 2004), mild cognitive impair-
ment (Bennys et al. 2011), Alzheimer’s disease (Lai et al.
2010) and schizophrenia (Hasey and Kiang 2013) but there
are no clinical applications in this field. In PD, the main
focus of research has been on the late component P300,
latency of which is usually prolonged in PD-MCI and PDD
or the response may be absent altogether. P300 latency and
amplitude have also been found to correlate to neuropsy-
chological disturbances such as impaired executive func-
tion and verbal fluency indicating that alterations in P300
reflect frontal lobe dysfunction in PD (Chen et al. 2006;
Tsuchiya et al. 2000).
Previous studies examining N100- and P200-potentials in
PD are few and the results have been contradictory. The P200
response is considered to reflect conscious stimulus process-
ing, which is often impaired or at least slowed in PD.
Accordingly, the latency of P200 has been prolonged in some
studies (Ebmeier et al. 1992; Hansch et al. 1982) but also
normal results have been reported (Goodin and Aminoff
1987). Also the N100 latency has been reported normal in a
number of studies concerning PD (Pekkonen et al. 1995;
Vieregge et al. 1994). This is rather unexpected considering
that the N100-potential most likely indicates stimulus detec-
tion and is, therefore, a measure of attention. It also associates
with working memory by directing attention towards mean-
ingful sensory information and blocking redundant stimuli
(Lee et al. 2010). Sustaining attention and ignoring irrele-
vancies are often impaired in PD as well as is working
memory. Considering these common cognitive deficits in PD
as well as the cognitive processes that the P200- and N100
potentials are considered to measure, one would expect to find
some association between P200- and N100 potentials and
neuropsychological test performance.
In the present study, we conducted EEG with ERPs to 18
PD-patients and 24 healthy controls to investigate neuro-
physiological differences between the groups. We
hypothesized that there would be alterations in the evoked
response potentials in the patient group and that these
alterations would reflect cognitive changes. Therefore, also
a neuropsychological examination was done for patients.
Methods
14 PD-patients were recruited from a previously described
population (Annanmaki et al. 2008). Due to dropouts in the
primary sample, 4 additional consecutive PD-patients from
the Neurological Outpatient Clinic of Jorvi Hospital of
Helsinki University Central Hospital (HUCS) were invited
to participate to the study. Inclusion criteria were idio-
pathic PD according to the UK Parkinson’s disease Brain
Bank Criteria(Hughes et al. 1992) and no clinical sign of
Parkinson’s disease dementia. Exclusion criteria were
current use of medications affecting plasma uric levels
other than levo-dopa. All the patients were examined by a
neurologist to evaluate Unified Parkinson’s disease Rating
Scale (UPDRS) motor score, Hoehn&Yahr stage and Mini
Mental State Examination (MMSE).
The controls were healthy volunteers from the hospital
staff and their acquaintances with no sign of a neurological
disease. Cognition was screened with Consortium to
establish Alzheimer’s disease (Cerad) -test series; a normal
result was required to exclude mild cognitive impairment.
The demographic variables of the patients and controls
are described in Table 1.
The study was approved by the Ethics Committee of
Helsinki and Uusimaa Health District Area. All patients
and controls signed a written informed consent.
Recording and quantification
of electroencephalography
EEG recording and stimuli to induce ERP were done
with a Cognitrace EEG/ERP-system version 3.3 (ANT
Neuro, Enschede, The Netherlands, later abbreviated
ANT). EEG was recorded with active shielded
64-channel Waveguard EEG caps with electrode layout
following the international 10–10-system, electrode
material Ag–AgCl (ANT) and with a DC-amplifier
REFA-64 (ANT) using sampling frequency of 256 Hz.
Cognitrace’s amplifier uses inbuilt common average
reference and it is constructed for direct current (DC)
measurements and hence no high-pass filtering was
applied. Impedances were made as low as possible.
Timing of the different stimuli and responses were
recorded together with the EEG.
Electro-oculogram (EOG) and electrocardiogram (ECG)
were also recorded.
ERP-recording
During ERP-recording the patients were asked to follow a
silent nature movie shown on a TV screen at a distance of
1.5 meters. Auditory stimuli were given through calibrated
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headphones (Telephonics TDH-39P) and the patients were
instructed not to pay attention to the tones.
The auditory ERPs were stimulated with pairs of tones
with an inter stimulus interval (ISI) of 0.5 s. The responses
to first and second tones of pairs with 0.5 s ISI were ana-
lyzed. ERP responses for 40 pairs of stimuli were averaged.
The interval between pairs of stimuli were 12 s. The
duration of the sound stimuli was 60.8 ms with rise and fall
times of 11 ms each, leaving about 40 ms of steady pla-
teau. Frequency of the stimuli was 1000 Hz and sound
pressure level 60 dB above the hearing threshold, mea-
sured before the ERP recording and with the same tones as
in the paradigm.
EEG-ERP analysis
The recordings were analyzed off-line using ASA software
version 4.8.0 (ANT). Only channels of the international
10-20 system (Fp1, Fp2, F7, F3, Fz, F4, F8, T3, C3, Cz,
C4, T4, T5, P3, Pz, P4, T6, O1 and O2) were considered in
the analysis. All data was first inspected visually and the
channels with excessive artifacts were removed prior to
further analysis.
Pre-processing and analysis of the recordings were done
with ASA-software version 4.6.2.0 (ANT). EEG was fil-
tered with a bandpass of 0.3–30 Hz (12 dB/octave roll-off).
Blink artefacts were removed by an algorithm based on
spatial filtering (Ille et al. 2002). The manually selected
prototypes of blinks per recording numbered at least ten.
After artefact correction, the data were re-referenced to
average reference and digitally filtered (high-pass 0.5 Hz,
low-pass 30 Hz, 24 dB/octave). Remaining artefacts were
excluded with amplitude criterion of ±75 lV before cal-
culating the averaged waveforms.
The continuous EEG data was transformed off-line to
600 ms epochs, starting 100 ms before the onset of each
stimulus. Finally, the averaged waveforms were baseline
corrected by the 100 ms preceding the stimulus as the
baseline. The amplitude and latency of N100 (Cz) and
P200 (Cz) elicited by the auditory stimuli were measured
with respect to the highest negativity in a 60-170 ms post
stimulus time interval and the highest positivity in a
100–260 ms interval, respectively. The results of the
automated peak detection were verified manually and
corrections performed when necessary. Habituation of the
N100 was calculated as the difference between the ampli-
tudes elicited by the first and second tones of a pair with
0.5 ms ISI.
Neuropsychological examination
Finnish translations of both traditional neuropsychological
tests and computerized tasks were applied.
Depression was assessed with a 21-item version of the
Beck Depression Inventory (BDI-II). General knowledge
was assessed with the information and similarities subtests
of the Wechsler Adult Intelligence Scale Revised (WAIS-
R).
Visuospatial and visuoconstructive functions were
assessed with the block design and picture completion
subtests of the WAIS-R. The digit span and digit symbol
subtests of the WAIS-R were used to assess working
memory. Verbal learning and memory were assessed with
the logical memory subtest of the Wechsler Memory Scale-
Revised (WMS-R) and the word list subtest of the Wech-
sler Memory Scale-Third Edition (WMS-III). Visual
memory was assessed with the visual reproduction subtest
of the WMS-R. Verbal fluency was assessed with two tests;
Table 1 The demographic
characteristics of the patients
and controls as well as the
latencies and amplitudes on the
N100 and P200 potentials
PD-patients (n = 18) Controls (n = 24)
Age (range) 62 (42–71) 67 (60–79)
Gender, % of males 44% 33%
MMSE (range) 28 (23–30) 28 (28–30)
Duration of disease in years, mean (range) 6 (2–13)
UPDRS, mean (range) 17 (1–51)
Levo-Dopa usage 13
Levo-Dopa dose, mean (range) 425 mg (250–875 mg)
Dopamine agonist 12
Selegiline 13
N100 latency, mean (SD) 107.6 (23.2)* 95.1 (16.6)*
N100 amplitude, mean (SD) -5.5 (2.0) -5.3 (2.0)
P200 latency, mean (SD) 208.5 (30.7) 214.6 (21.5)
P200 amplitude, mean (SD) 5.3 (2.8) 4.3 (1.7)
* Mann–Whitney p = 0.05
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at first the subject was asked to list as many animals in a
minute as he/she could and then words that begin with the
letter K.
Executive function was assessed with two traditional
neuropsychological tests as well as computerized tasks. Of
the traditional tests, Trail making and Rule shift cards tests
from Behavioral Assessment of the Dysexecutive syn-
drome (BADS) were used. Computerized tasks included
seven tasks from the Cognispeed for Windows 1.0 soft-
ware (Revonsuo and Portin 1995). Reaction times were
measured with simple-, two-choice- and ten-choice-tasks.
Subtraction-, statement verification- and Stroop-type tasks
were used to assess controlled cognitive processing and
attention. Stroop effect was measured using two separate
colour-word naming tests. First the subjects were asked to
read colour names written in concordant colour (e.g., blue
written in blue) to measure facilitation and then in dis-
cordant colour (e.g., red written in blue) to measure
interference. Vigilance task was used to measure sustaining
attention. This is a monotonous task lasting 15 min during
which letters appear on the screen. Among them are two
target letters occurring at random in a relatively slow rate.
Statistics
The statistical analysis was carried out using IBM SPSS
Statistics 20 software. Due to the small sample size and
non-normal distribution of some of the data, only non-
parametric tests were applied. Kruskal–Wallis Test for
Several Independent samples was used to analyze overall
variance in the neuropsychological performance. The N100
latency median, P200 latency median and N100 amplitude
habituation median were used as a grouping variable in the
respective analysis. Mann–Whitney test was used to com-
pare the mean latencies and amplitudes of N100 and P200
potentials and Spearman rank to measure correlation
between the neurophysiological and neuropsychological
parameters.
Results
The PD-patient’s and controls clinical and demographic
characteristics as well as the latencies and amplitudes of
N100 and P200 are described in Table 1. Three patients did
not attend to the neuropsychological evaluation leaving 15
patients for the respective analysis. The patients and con-
trols were age matched apart from one outlier in the patient
group (a 43 year old woman). The statistical analysis was
repeated after the exclusion of the outlier and the results
did not change significantly.
The N100 latency was prolonged in the patients com-
pared to the controls with borderline significance (Mann–
Whitney, p = 0.05). There were no other significant dif-
ferences in the N100 and P200 latencies or amplitudes
between the two groups. Figure 1 shows the ERP grand
averages for the patients and controls. The habituation of
the N100-amplitude was more pronounced in the controls
compared to the patients, though this finding did not reach
statistical significance.
In the Kruskal–Wallis test the performance in several
neuropsychological tests varied according to N100 latency
and amplitude habituation but there was no variance with
respect to the P200 latency. The results of the Kruskal–
Wallis test are displayed in Table 2. The neuropsycho-
logical tests with statistically significant variance were
chosen for further statistical analysis.
In the patient group, the N100 latency showed a sig-
nificant negative correlation with the delayed visual
reproduction of the WMS-R (Spearman rank R = -0.62,
p = 0.010) and a trend towards negative correlation with
the immediate recall of the word list of the WMS-III
(Spearman rank R = -0.53, p = 0.056). Habituation of
the N100-amplitude correlated with delayed visual repro-
duction (Spearman rank R = 0.57, p = 0.026). The
patients were divided into two groups according to the
median of the delayed visual reproduction result. The
patients with above median result had shorter N100
latencies and stronger habituation as shown in Table 3.
There was no correlation between the N100 latency or
habituation and age, disease duration from the diagnosis,
UPDRS-motor score and daily levo-dopa dose in the
patients.
Discussion
In the present study the N100 latency was prolonged in PD-
patients compared to healthy controls. This finding is in
accordance with previous studies by Jiang et al. (2000) and
Raudino et al. (1997). The latter also performed neu-
ropsychological testing but did not find an association
between cognition and the N100-potential. Interestingly,
the N100 latency has been reported normal in a previous
study concerning amnestic MCI and Alzheimer’s disease
(Lai et al. 2010) suggesting that prolonged latency of the
N100 might aid in differentiating PD-related cognitive
decline from these other common neurocognitive disorders.
The association of the N100 latency and amplitude
habituation with a visual working memory task is inter-
esting considering that problems in visuospatial abilities
and working memory are common even in the early stages
of PD (Aarsland et al. 2008; Kandiah et al. 2009; Mus-
limovic et al. 2005; Uc et al. 2005). Although at this stage
the neuropathological changes of PD are confined to brain
stem and basal ganglia (Braak et al. 2003), the ensuing
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dopaminergic defect disturbs connections between striatum
and frontal cortex. This frontostriatal dysfunction leads to
early cognitive alterations such as poor attention and
diminished working memory capacity (Jokinen et al. 2013;
Lewis et al. 2003). Attention and working memory
capacity are closely interconnected as previous studies
indicate that working memory is under attentional control
that is mediated by basal ganglia (Fielding et al. 2006; Lee
et al. 2010; McNab and Klingberg 2008). The memory
problems in PD may, therefore, partly be due to poor
ability to filter out irrelevant information from taking space
in easily overloading working memory. The N100 evoked
response potential is considered a measure of focusing
attention, demanding also suppression of irrelevant stimuli.
The patients’ difficulty in focusing attention would,
therefore, explain the close connection of prolonged N100
latency and poor amplitude habituation with the visual
working memory task. This hypothesis is in conjunction
with previous work presented by Lijffijt et al. (2009),
Brumback et al. (2004) and Soininen et al. (1995), who
found N100 response to be associated with visual working
memory and working memory span. The studied subjects
were healthy volunteers from a community sample as there
are no studies including PD-patients. These previous
studies increase our knowledge of the N100 potential as a
measure of attention and working memory although the
number of subjects in the studies has been rather low. Also
our results must be interpreted with caution considering the
small sample size. Larger studies are needed to corroborate
our findings and also to better control for possible con-
founding factors such as medication and mood.
Fig. 1 Auditory event-related potentials in response to the first (black) and second (gray) tone of a pair of tones (ISI 0.5s) measured at the central
(Cz) electrode location
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Word list A (delayed) p = 0.03
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Table 3 The difference between the N100 latency and amplitude
habituation in the patient groups defined by the performance in the
















-1.7 (1.8) -3.4 (1.6) p = 0.04
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Why haven’t the previous studies found consistently
prolonged N100 latency or altered N100 habituation in
PD? All previous studies, as well as ours, include only a
small number of patients with a large spectrum of age,
duration of disease and disease severity. The statistical
power to detect subtle differences in these patient samples
has been rather low. Also methodological differences in
EEG-ERP recordings and signal averaging may explain the
inconsistent findings.
The treatment of cognitive decline remains an enigma.
There is some evidence that life style factors such as
exercising and social activity, as well as optimal treatment
of vascular risk factors may help to preserve cognition in
neurodegenerative diseases such as PD (Ngandu et al.
2015). Exercise has also been found to cause augmentation
of the N100 amplitude in healthy elderly adults (Chang
et al. 2013) and our findings further supports regular
exercise as a part of PD treatment regimen.
The obvious limitation of our study is the small sample
size, with many PD-patients not participating because of
the laborious protocol.
We conclude that prolonged N100 latency and poor
amplitude habituation have interesting associations with
visual working memory in PD. Ours study adds to knowledge
of the mechanisms of working memory impairment in PD
and corroborates previous findings that link attention and
working memory capacity. As to date there is too little
information to judge if a clinical application of ERP-mea-
surement would be useful in the diagnosis of cognitive
decline and dementia in PD.
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